Orchestra BioMed
OBIO
OBIO
47 hedge funds and large institutions have $116M invested in Orchestra BioMed in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 4 closing their positions.
Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
23
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$15.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$3.12M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$4.53M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$10.5M |
| 5 |
5
Bank of New York Mellon
New York
|
$576K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
51
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
52
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 19 | +17 | +850% |
|